Alembic Ltd - Stock Valuation and Financial Performance

BSE: 506235 | NSE: ALEMBICLTD | Pharmaceuticals & Drugs | Small Cap

Alembic Share Price

83.75 3.57 4.45%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Alembic

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Alembic stock performance -

mw4me loader
P/E Ratio (CD):
8.41
Market Cap:
2,058.9 Cr.
52-wk low:
55.5
52-wk high:
107.5

Is Alembic Ltd an attractive stock to invest in?

1. Is Alembic Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Alembic Ltd is a average quality company.

2. Is Alembic Ltd undervalued or overvalued?

The key valuation ratios of Alembic Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Alembic Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Alembic Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Alembic:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Alembic Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 8.6%16.8%35.3%17.3%15.6%18.5%25%18.3%9.2%8.6%-
Value Creation
Index
-0.40.21.50.20.10.30.80.3-0.4-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1,13814412814712512473.973.578.2127146
Sales YoY Gr.--87.4%-11.4%15.4%-14.9%-1.2%-40.3%-0.6%6.4%62.7%-
Adj EPS 1.548.85.55.98.312.813.28.57.79.5
YoY Gr.-166%120.3%-37%5.6%41.2%54.5%3.5%-35.3%-10.4%-
BVPS (₹) 12.619.830.134.140.747.155.289.597.280.982.9
Adj Net
Profit
40106235148156212328339219196245
Cash Flow from Ops. 149229.751.623.621.56.5-2.2-17.838.9-
Debt/CF from Ops. 2.7000000-0.100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -21.6%0.3%19.8%62.7%
Adj EPS 19.8%5.5%-15.7%-10.4%
BVPS22.9%14.8%13.6%-16.8%
Share Price 18.4% 15% -6.7% 48.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
1224.635.317.315.618.524.918.39.28.611.6
Op. Profit
Mgn %
10.264.74.68.814.64.314.217.831.731.7
Net Profit
Mgn %
3.516.719.520.527.832.4123.713.6106.767.9168.1
Debt to
Equity
1.2000000000-
Working Cap
Days
192945404248217175258336488362202
Cash Conv.
Cycle
733642591681318211018427722781

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 19.84%

Sales growth is good in last 4 quarters at 46.25%

Return on Equity has declined versus last 3 years average to 11.60%

Net Profit has been subdued in last 3 years -15.68%

Latest Financials - Alembic Ltd.

Standalone Consolidated
TTM EPS (₹) 3 9.5
TTM Sales (₹ Cr.) 141 146
BVPS (₹.) 33.2 82.9
Reserves (₹ Cr.) 801 2,078
P/BV 2.41 0.97
PE 26.92 8.41
From the Market
52 Week Low / High (₹) 55.52 / 107.50
All Time Low / High (₹) 0.68 / 143.30
Market Cap (₹ Cr.) 2,059
Equity (₹ Cr.) 51.4
Face Value (₹) 2
Industry PE 47.8

Management X-Ray of Alembic:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales1,138144128147125124747478127
Operating Expenses 1,02413512214011410671636487
Manufacturing Costs1262519137926689
Material Costs571747096796712222341
Employee Cost 145272423202121232124
Other Costs 18199991011121213
Operating Profit 11596711173101440
Operating Profit Margin (%) 10.1%6.0%4.7%4.6%8.8%14.0%4.2%14.2%17.8%31.7%
Other Income 10222931373094118964
Interest 38100000000
Depreciation 43665433457
Exceptional Items 00-3-600000-11
Profit Before Tax 44232527444593179887
Tax 4-11-12403126
Profit After Tax 40242527424193148681
PAT Margin (%) 3.5%16.8%19.4%18.7%33.3%33.2%125.8%18.8%110.2%63.4%
Adjusted EPS (₹)1.54.08.85.46.18.312.813.48.77.4
Dividend Payout Ratio (%)17%4%2%4%3%2%5%2%21%30%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 3375288039111,0861,2091,4182,2972,4972,078
Share Capital 27535353535151515151
Reserves 3114747508581,0321,1571,3672,2462,4452,027
Minority Interest0000000000
Debt408000000000
Long Term Debt408000000000
Short Term Debt0000000000
Trade Payables198191615162513181917
Others Liabilities 86101566657334094116109
Total Liabilities 1,0296488759921,1591,2661,4712,4092,6322,205

Fixed Assets

Gross Block712402372158144145145150151151
Accumulated Depreciation31923322511121315161819
Net Fixed Assets393169146148132131131134134132
CWIP 42003222193700
Investments 82995897329131,0011,1332,0472,2081,754
Inventories245847551323535548789
Trade Receivables19348282225149141523
Cash Equivalents 243221259722
Others Assets162423538246086116186205
Total Assets 1,0296488759921,1591,2661,4712,4092,6322,205

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 14922105224227-2-1839
PBT 44232527444593179887
Adjustment 73-12-17-21-29-21-862-79-53
Changes in Working Capital 36102461221-19-2811
Tax Paid -41-10-4-5-2-2-9-7
Cash Flow From Investing Activity -235-5-47-227257-35197
Capex -2801-14-9-23-22-47-34-25
Net Investments 0-14-28-59-3871-1011-27-26
Others 419222625248818058
Cash Flow From Financing Activity -118-25-5-5-3-92-6-15-6-46
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0200200000
Interest Paid -36-100000000
Dividend Paid -5-5-5-5-5-6-6-15-5-46
Others -77-22000-850000
Net Cash Flow 7200-1157-52-50
PARTICULARSMar'10Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)11.835.583.713.214.183.587.080.753.63.52
ROCE (%)10.543.823.823.124.443.917.120.944.13.82
Asset Turnover Ratio1.110.180.180.160.120.10.050.040.030.05
PAT to CFO Conversion(x)3.730.920.41.930.570.540.08-0.14-0.210.48
Working Capital Days
Receivable Days6429410359675756576855
Inventory Days77402217150119100175223329252
Payable Days117534935972112566253299163

Alembic Ltd Stock News

Alembic Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Alembic on 28-Mar-2024 16:01 is ₹83.75.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Alembic stood at ₹2,058.9.
The latest P/E ratio of Alembic as of 28-Mar-2024 16:01 is 26.92.
The latest P/B ratio of Alembic as of 28-Mar-2024 16:01 is 2.41.
The 52-week high of Alembic is ₹107.5 and the 52-week low is ₹55.52.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alembic is ₹140.8 ( Cr.) .

About Alembic Ltd

Alembic is a Public Limited Company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised stock exchanges in India. The registered office of the Company is located at Alembic Road, Vadodara, Gujarat. The Company is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

Business area of the company

The company is primarily engaged in two businesses i.e.

API Manufacturing

  • Estolate
  • Biphenyl Valine Oxalate
  • Venlafaxine

Real Estate

  • Residential Projects
  • Commercial Project
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.